Clinical and Experimental Effects of Reserpine in Patients with Essential Hypertension
In this article, Freis and Ari presented the clinical data on their research for the ganglionic-blocking agent reserpine.
They determined that it was ideal for treatment of mild hypertension, but because of its additive qualities, could be used
in conjunction with other antihypertensive agents, such as hydralazine, for more severe cases.
Item is a photocopy.
Number of Image Pages:
9 (796,651 Bytes)
1954-04-30 (April 30, 1954)
Freis, Edward D.
Periodical: Freis, Edward D., and Recep Ari. "Clinical and Experimental Effects of Reserpine in Patients with Essential Hypertension."
Annals of the New York Academy of Sciences 59, (30 April 1954): 45-53. Article. 9 Images.
New York Academy of Sciences
Reproduced with permission of Blackwell Scientific Publications.
Medical Subject Headings (MeSH):
The Veterans Administration Hospital and Georgetown University School of Medicine, 1949-1964